These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12042986

  • 1. Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).
    Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S25-8. PubMed ID: 12042986
    [Abstract] [Full Text] [Related]

  • 2. Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).
    Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C, Neumaier C, Conte PF, Rosso R, Italian Lung Cancer Task Force.
    Br J Cancer; 2001 Nov 16; 85(10):1452-5. PubMed ID: 11720427
    [Abstract] [Full Text] [Related]

  • 3. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G, Gruppo Ocologico Italia Meridionale.
    Lung Cancer; 2003 Feb 16; 39(2):179-89. PubMed ID: 12581571
    [Abstract] [Full Text] [Related]

  • 4. Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.
    Recchia F, Lombardo M, De Filippis S, Rosselli M, Rea S.
    Anticancer Res; 2002 Feb 16; 22(2B):1321-8. PubMed ID: 12168945
    [Abstract] [Full Text] [Related]

  • 5. Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
    Kosmas C, Tsavaris N, Panopoulos C, Vadiaka M, Stavroyianni N, Kourelis T, Malamos N, Antonopoulos M, Kalofonos HP.
    Eur J Cancer; 2001 May 16; 37(8):972-8. PubMed ID: 11334721
    [Abstract] [Full Text] [Related]

  • 6. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G, Kies MS, Zinner R, Jung MS, Lu R, Lee JJ, Munden RF, Hong WK, Lee JS.
    Cancer; 2002 Jul 15; 95(2):340-53. PubMed ID: 12124835
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M, Villar Chamorro E, Alés Díaz I, Gil Calle S, Alcalde García J, Gutiérrez Calderón V, Carabantes Ocón F, Montesa Pino A, Bretón García JJ, Benavides Orgaz M.
    Clin Transl Oncol; 2006 Oct 15; 8(10):742-9. PubMed ID: 17074673
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
    Isokangas OP, Knuuttila A, Halme M, Mäntylä M, Lindström I, Nikkanen V, Viren M, Joensuu H, Mattson K.
    Ann Oncol; 1999 Sep 15; 10(9):1059-63. PubMed ID: 10572603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study.
    Piantedosi FV, Caputo F, Mazzarella G, Gilli M, Pontillo A, D'Agostino D, Campbell S, Marsico SA, Bianco A.
    Cancer Chemother Pharmacol; 2008 Apr 15; 61(5):803-7. PubMed ID: 17639396
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study.
    Camps C, Martínez EN, Jaime AB.
    Lung Cancer; 2000 Jan 15; 27(1):47-53. PubMed ID: 10672783
    [Abstract] [Full Text] [Related]

  • 16. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.
    Keskin S, Tas F, Ekenel M, Kilic L, Sen F, Yildiz I, Karabulut S, Ciftci R, Vatansever S.
    Tumori; 2013 Jan 15; 99(4):463-8. PubMed ID: 24326833
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study.
    Recchia F, De Filippis S, Rosselli M, Pompili P, Guerriero G, Rea S.
    Eur J Cancer; 1999 Oct 15; 35(10):1457-61. PubMed ID: 10673977
    [Abstract] [Full Text] [Related]

  • 18. Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
    Palmeri S, Leonardi V, Gebbia V, De Bella MT, Ferraù F, Faillú G, Spatafora M, Valenza R, Di Vita G, Vitello S, Carroccio R, Sciortino G, Vaglica M, Accurso V, Agostara B, Licata G.
    Lung Cancer; 2001 Oct 15; 34(1):115-23. PubMed ID: 11557121
    [Abstract] [Full Text] [Related]

  • 19. A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.
    Chen YM, Perng RP, Chen MC, Tsai CM, Ming-Liu J, Whang-Peng J.
    Lung Cancer; 2003 May 15; 40(2):221-6. PubMed ID: 12711125
    [Abstract] [Full Text] [Related]

  • 20. A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).
    Grigorescu A, Ciuleanu T, Firoiu E, Muresan DR, Teodorescu G, Basson BR.
    Lung Cancer; 2007 Aug 15; 57(2):168-74. PubMed ID: 17467848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.